These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32333853)

  • 21. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
    Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
    Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep vein thrombosis and pulmonary embolism.
    Di Nisio M; van Es N; Büller HR
    Lancet; 2016 Dec; 388(10063):3060-3073. PubMed ID: 27375038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
    Tosetto A; Iorio A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Douketis J
    J Thromb Haemost; 2012 Jun; 10(6):1019-25. PubMed ID: 22489957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-dimer testing to determine the duration of anticoagulation therapy.
    Palareti G; Cosmi B; Legnani C; Tosetto A; Brusi C; Iorio A; Pengo V; Ghirarduzzi A; Pattacini C; Testa S; Lensing AW; Tripodi A;
    N Engl J Med; 2006 Oct; 355(17):1780-9. PubMed ID: 17065639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study.
    Pengo V; Palareti G; Cosmi B; Legnani C; Tosetto A; Alatri A; Marzot F; Pegoraro C; Cucchini U; Iliceto S;
    Thromb Haemost; 2008 Oct; 100(4):718-21. PubMed ID: 18841301
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
    Eichinger S; Heinze G; Jandeck LM; Kyrle PA
    Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
    Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
    Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
    Raskob G; Ageno W; Cohen AT; Brekelmans MP; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Lancet Haematol; 2016 May; 3(5):e228-36. PubMed ID: 27132697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated with Pulmonary Embolism Recurrence and the Benefits of Long-term Anticoagulant Therapy.
    Anniccherico-Sanchez FJ; Alonso-Martinez JL; Urbieta-Echezarreta MA; Villar-Garcia I; Rojo-Alvaro J
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(3):205-211. PubMed ID: 28925904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.
    Tritschler T; Limacher A; Méan M; Rodondi N; Aujesky D
    Am J Med; 2017 Oct; 130(10):1221-1224. PubMed ID: 28522384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).
    Tullett J; Murray E; Nichols L; Holder R; Lester W; Rose P; Hobbs FD; Fitzmaurice D
    BMC Cardiovasc Disord; 2013 Mar; 13():16. PubMed ID: 23497371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unfavorably altered plasma clot properties in women with a HERDOO2 score equal to or greater than 2 and prediction of recurrent venous thromboembolism.
    Mrozińska S; Cieślik J; Broniatowska E; Undas A
    Pol Arch Intern Med; 2018 Oct; 128(10):572-579. PubMed ID: 30113019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
    Planquette B; Ferré A; Peron J; Vial-Dupuy A; Pastre J; Mourin G; Emmerich J; Collignon MA; Meyer G; Sanchez O
    Thromb Res; 2016 Dec; 148():70-75. PubMed ID: 27815969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six months
    Couturaud F; Pernod G; Presles E; Duhamel E; Jego P; Provost K; Pan-Petesch B; Sollier CBD; Tromeur C; Hoffmann C; Bressollette L; Lorillon P; Girard P; Le Moigne E; Le Hir A; Guégan M; Laporte S; Mismetti P; Lacut K; Bosson JL; Bertoletti L; Sanchez O; Meyer G; Leroyer C; Mottier D;
    Haematologica; 2019 Jul; 104(7):1493-1501. PubMed ID: 30606789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model.
    Eichinger S; Heinze G; Kyrle PA
    J Am Heart Assoc; 2014 Jan; 3(1):e000467. PubMed ID: 24385451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.